Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)

Systemic Juvenile Idiopathic Arthritis

Novartis Pharmaceuticalsmonoclonal_antibodyPhase 3Active
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Systemic Juvenile Idiopathic Arthritis cohort.

Asset / SponsorPhaseRating
Anakinra
Institut National de la Santé Et de la Recherche Médicale, France
Phase 2/3B
Pneumo23
Institut National de la Santé Et de la Recherche Médicale, France
Phase 2/3B
Thiotepa
Paul Szabolcs
Phase 2CCC
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Paul Szabolcs
Phase 2CCC
Fludarabine
Paul Szabolcs
Phase 2CCC
Evomela
Paul Szabolcs
Phase 2CCC
Hydroxyurea
Paul Szabolcs
Phase 2CCC

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION) is also rated in:

COVID-19Dormant
B
Indicative ·
58 / 100
View asset →
hereditary periodic fever syndromeDormant
B
Indicative ·
58 / 100
View asset →
type 2 diabetes mellitusDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →